Exosens Balance Sheet Health
Financial Health criteria checks 4/6
Exosens has a total shareholder equity of €382.0M and total debt of €250.7M, which brings its debt-to-equity ratio to 65.6%. Its total assets and total liabilities are €784.3M and €402.3M respectively. Exosens's EBIT is €64.1M making its interest coverage ratio 1.5. It has cash and short-term investments of €123.2M.
Key information
65.6%
Debt to equity ratio
€250.70m
Debt
| Interest coverage ratio | 1.5x |
| Cash | €123.20m |
| Equity | €382.00m |
| Total liabilities | €402.30m |
| Total assets | €784.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EXENS's short term assets (€315.9M) exceed its short term liabilities (€111.7M).
Long Term Liabilities: EXENS's short term assets (€315.9M) exceed its long term liabilities (€290.6M).
Debt to Equity History and Analysis
Debt Level: EXENS's net debt to equity ratio (33.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if EXENS's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: EXENS's debt is well covered by operating cash flow (29.7%).
Interest Coverage: EXENS's interest payments on its debt are not well covered by EBIT (1.5x coverage).